Zynex Gross Margin 2010-2023 | ZYXI
Current and historical gross margin for Zynex (ZYXI) over the last 10 years. The current gross profit margin for Zynex as of December 31, 2023 is %.
| Zynex Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.18B | $0.15B | 79.35% |
| 2023-09-30 | $0.19B | $0.15B | 79.57% |
| 2023-06-30 | $0.18B | $0.14B | 79.21% |
| 2023-03-31 | $0.17B | $0.13B | 78.82% |
| 2022-12-31 | $0.16B | $0.13B | 78.62% |
| 2022-09-30 | $0.15B | $0.12B | 79.33% |
| 2022-06-30 | $0.14B | $0.11B | 79.72% |
| 2022-03-31 | $0.14B | $0.11B | 79.56% |
| 2021-12-31 | $0.13B | $0.10B | 79.23% |
| 2021-09-30 | $0.12B | $0.09B | 77.59% |
| 2021-06-30 | $0.10B | $0.08B | 77.23% |
| 2021-03-31 | $0.09B | $0.07B | 77.53% |
| 2020-12-31 | $0.08B | $0.06B | 78.75% |
| 2020-09-30 | $0.07B | $0.05B | 79.41% |
| 2020-06-30 | $0.06B | $0.05B | 80.00% |
| 2020-03-31 | $0.05B | $0.04B | 80.39% |
| 2019-12-31 | $0.05B | $0.04B | 80.00% |
| 2019-09-30 | $0.04B | $0.03B | 85.00% |
| 2019-06-30 | $0.04B | $0.03B | 83.33% |
| 2019-03-31 | $0.03B | $0.03B | 82.35% |
| 2018-12-31 | $0.03B | $0.03B | 78.13% |
| 2018-09-30 | $0.03B | $0.02B | 74.19% |
| 2018-06-30 | $0.03B | $0.02B | 73.33% |
| 2018-03-31 | $0.03B | $0.02B | 74.07% |
| 2017-12-31 | $0.02B | $0.02B | 82.61% |
| 2017-09-30 | $0.02B | $0.02B | 94.44% |
| 2017-06-30 | $0.02B | $0.02B | 100.00% |
| 2017-03-31 | $0.01B | $0.01B | 100.00% |
| 2016-12-31 | $0.01B | $0.01B | 76.92% |
| 2016-09-30 | $0.01B | $0.01B | 46.15% |
| 2016-06-30 | $0.01B | $0.01B | 41.67% |
| 2016-03-31 | $0.01B | $0.01B | 41.67% |
| 2015-12-31 | $0.01B | $0.01B | 58.33% |
| 2015-09-30 | $0.01B | $0.01B | 63.64% |
| 2015-06-30 | $0.01B | $0.01B | 66.67% |
| 2015-03-31 | $0.01B | $0.00B | 40.00% |
| 2014-12-31 | $0.01B | $0.00B | 40.00% |
| 2014-09-30 | $0.01B | $0.00B | 36.36% |
| 2014-06-30 | $0.01B | $0.01B | 41.67% |
| 2014-03-31 | $0.02B | $0.01B | 68.75% |
| 2013-12-31 | $0.02B | $0.01B | 66.67% |
| 2013-09-30 | $0.03B | $0.02B | 72.41% |
| 2013-06-30 | $0.03B | $0.03B | 73.53% |
| 2013-03-31 | $0.04B | $0.03B | 74.36% |
| 2012-12-31 | $0.04B | $0.03B | 77.50% |
| 2012-09-30 | $0.04B | $0.03B | 76.92% |
| 2012-06-30 | $0.04B | $0.03B | 76.32% |
| 2012-03-31 | $0.04B | $0.03B | 77.78% |
| 2011-12-31 | $0.03B | $0.03B | 76.47% |
| 2011-09-30 | $0.03B | $0.02B | 77.42% |
| 2011-06-30 | $0.03B | $0.02B | 75.86% |
| 2011-03-31 | $0.03B | $0.02B | 74.07% |
| 2010-12-31 | $0.03B | $0.02B | 76.00% |
| 2010-09-30 | $0.02B | $0.02B | 78.26% |
| 2010-06-30 | $0.02B | $0.02B | 80.95% |
| 2010-03-31 | $0.02B | $0.02B | 84.21% |
| 2009-12-31 | $0.02B | $0.02B | 88.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.350B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
| Stryker (SYK) | United States | $127.230B | 30.47 |
| Medtronic (MDT) | Ireland | $113.715B | 16.10 |
| Boston Scientific (BSX) | United States | $109.372B | 34.84 |
| EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
| ResMed (RMD) | United States | $32.315B | 30.34 |
| Terumo (TRUMY) | Japan | $26.460B | 37.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
| Baxter (BAX) | United States | $17.922B | 12.74 |
| Insulet (PODD) | United States | $12.984B | 57.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
| BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
| Haemonetics (HAE) | United States | $4.815B | 23.82 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
| Envista Holdings (NVST) | United States | $3.288B | 13.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
| QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
| Neogen (NEOG) | United States | $2.905B | 27.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
| TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
| ICU Medical (ICUI) | United States | $2.589B | 22.85 |
| Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
| Warby Parker (WRBY) | United States | $1.600B | 0.00 |
| InMode (INMD) | Israel | $1.565B | 8.32 |
| Owens & Minor (OMI) | United States | $1.462B | 12.74 |
| AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| AtriCure (ATRC) | United States | $1.077B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
| Evolus (EOLS) | United States | $0.858B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| PetIQ (PETQ) | United States | $0.583B | 19.05 |
| TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
| Jin Medical (ZJYL) | China | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.486B | 30.43 |
| ZimVie (ZIMV) | United States | $0.463B | 39.49 |
| Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
| Cerus (CERS) | United States | $0.362B | 0.00 |
| Biote (BTMD) | United States | $0.362B | 8.34 |
| MacroGenics (MGNX) | United States | $0.321B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
| Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.19 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.54 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.62 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |